Bridging the Innovation Gap with Biopharma Partnerships

With impending patent expirations and increased drug development times, the biopharma industry faces an innovation gap. Bridging this gap and maintaining or increasing the pipeline replenishment rate is essential for revenue growth. However, this rate is also falling, with the 25 top biopharma companies experiencing a drop of over 50%. One potential strategy to help stem the tide and support development is an ecosystem-based approach.

According to Arda Ural, PhD, “Ecosystems are business arrangements between two or more entities designed to create and share a higher level of value collectively for a common set of customers than the members can create individually considering time, capital, brand permission, market access, and other real-world constraints.”

To learn more, click here.

(Source: Bioprocess Online, May 18^th, 2022)